ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,118.80
-0.50%
S&P ASX All Technology
3,503.30
-0.53%
Brent Oil
72.905
0.00%
US Dollar vs AUD
1.52486
0.00%
Bitcoin
69,144.73
-0.49%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Capricor Therapeutics Inc (CAPR) Share Price

Capricor Therapeutics Inc

Capricor Therapeutics Inc (CAPR)

Caprock Mining Corp
19.45
-0.65
(-3.23%)
Closed 03 November 7:00AM
Delayed by 15 minutes
19.35
-0.10
(-0.51%)
After Hours: 10:48AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
19.35
Bid
19.34
Offer
19.80
Volume
791,925
19.27 Day's Range 20.74
2.68 52 Week Range 23.40
Market Cap
629.628M
Previous Close
20.10
Open
20.25
Last Trade
90
@
19.51
Last Trade Time
Financial Volume
US$ 15,794,433
VWAP
19.9444
Average Volume (3m)
3,186,614
Shares Outstanding
32,538,930
Dividend Yield
-
PE Ratio
-28.41
Earnings Per Share (EPS)
-0.69
Revenue
25.18M
Net Profit
-22.29M

About Capricor Therapeutics Inc

Capricor Therapeutics, Inc. is a San Diego based biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases. Capricor's lead candidate, CAP-1002, is an allogeneic cardiac-derived cell t... Capricor Therapeutics, Inc. is a San Diego based biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases. Capricor's lead candidate, CAP-1002, is an allogeneic cardiac-derived cell therapy that is currently in late-stage clinical development for treating Duchenne muscular dystrophy (DMD). Capricor is also developing its exosome technology as a next-generation therapeutic platform. Capricor's proprietary StealthX¿ exosome platform has potential for a broad range of new therapeutic applications in the field of vaccinology as well as targeted oligonucleotide, protein and small molecule therapeutics to treat or prevent a variety of diseases. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.capricor.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Capricor Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CAPR. The last closing price for Capricor Therapeutics was US$20.10. Over the last year, Capricor Therapeutics shares have traded in a share price range of US$ 2.68 to US$ 23.40.

Capricor Therapeutics currently has 32,538,930 shares in issue. The market capitalisation of Capricor Therapeutics is US$654.03 million. Capricor Therapeutics has a price to earnings ratio (PE ratio) of -28.41.

Ask ADVFN Intelligence (AI)

Capricor Therapeutics (CAPR) Options Flow Summary

CAPR Options Flow

Overall Flow

Bullish

Net Premium

2M

Calls / Puts

100.00%

Buys / Sells

57.14%

OTM / ITM

9.09%

Sweeps Ratio

0.00%

CAPR Latest News

More News

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

25 October 2024
Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933

23 October 2024
Edgar (US Regulatory)

Capricor Therapeutics Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

SAN DIEGO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare...

19 October 2024
GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]

18 October 2024
Edgar (US Regulatory)

Form 8-K - Current report

17 October 2024
Edgar (US Regulatory)

Capricor Therapeutics Announces Pricing of Approximately $75 Million Public Offering of Common Stock

SAN DIEGO, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare...

17 October 2024
GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness

17 October 2024
Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]

17 October 2024
Edgar (US Regulatory)

Form 8-K - Current report

17 October 2024
Edgar (US Regulatory)

Capricor Therapeutics Announces Proposed Public Offering of Common Stock

SAN DIEGO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare...

17 October 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-2.24-10.375173691521.5922.919.35115631921.43571631CS
41.458.1005586592217.923.415.34298789919.75702706CS
1215.44394.8849104863.9123.43.709318661413.80218996CS
2614.07266.4772727275.2823.43.52167383612.78416403CS
5216.53586.1702127662.8223.42.6898744711.66252454CS
15615.61417.3796791443.7423.42.564456649.70474792CS
26016.75644.2307692312.623.40.888755667.30086177CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VSTEVast Renewable Ltd
US$ 4.98
(149.00%)
68.54M
INVZWInnoviz Technologies Ltd
US$ 0.096
(96.71%)
22.71k
CDXCChromaDex Corporation
US$ 5.87
(68.19%)
37.88M
ATHAAthira Pharma Inc
US$ 0.606
(41.56%)
239.63M
TILEInterface Inc
US$ 23.24
(33.03%)
2.16M
EPIXESSA Pharma Inc
US$ 1.45
(-72.12%)
34.3M
ELABElevai Labs Inc
US$ 0.0288
(-51.19%)
202.28M
OSTOstin Technology Group Company Ltd
US$ 0.275
(-45.00%)
2.27M
LXRXLexicon Pharmaceuticals Inc
US$ 1.23
(-36.92%)
21M
VCIGVCI Global Ltd
US$ 0.0583
(-27.58%)
26.57M
ATHAAthira Pharma Inc
US$ 0.606
(41.56%)
239.63M
SQQQProShares UltraPro Short QQQ
US$ 7.44
(-2.11%)
216.16M
NVDANVIDIA Corporation
US$ 135.40
(1.99%)
209.27M
ELABElevai Labs Inc
US$ 0.0288
(-51.19%)
202.28M
INTCIntel Corporation
US$ 23.20
(7.81%)
173.47M

CAPR Discussion

View Posts
Laster Laster 5 days ago
Excellent that $21 support held. I was nervous for a little bit.
Now let’s break $22.50 so we can have clear sailing to $30 with target $35.
I am confident (sort of) that this will occur.
Here’s hoping.
👍 1
Laster Laster 5 days ago
Failed $22.50 break multiple times.
Probably time to consolidate before next run.
Might drop and find support at $19.50.
Hopefully not.
Still looking and hoping for volume to power this past $22.50 for good.
👍️0
Laster Laster 7 days ago
The stock chart is showing a nice ascending triangle from Sept 30th breakout from $10.
Using my novice chart skills, I get a target of $35 for the stock (flag pole from $10 to resistance at $22.50 = $12.50).
$22.50 plus $12.50 = $35. Sounds good to me.
Lower trendline has shown nice support but if the stock moves back to $20 then stock might drop back to $17.50.
Let’s what happens this week.
Hoping for move to $25 if the market looks good.
👍️0
staynafloat staynafloat 7 days ago
I think what helped the most is that the OS is only 44.7 Mil. with that added in. It appears that a lot of traders are holding making it trade very thin.

LOL ... I've been waiting for almost 5 years for this to go thru all the trials and testing and it sure is sweet :)
👍️0
GreedyAgorist GreedyAgorist 7 days ago
That dilution went about as well as any I’ve seen. The news did not even bring us below 18 for more than a wick or two. Correct me if I’m wrong, but the underwriters made out quite well, at least an extra dollar per additional share issued (~5M). Nice work if you can get it.
👍️0
Laster Laster 1 week ago
Sounds good.
Hopefully yesterday was a technical sell off to show $20 support level.
Maybe get rid of those low hanging stop loss orders.
I am not worried about another financing so I expect a nice move to $25 then $30 by EOY.
Enjoy.
👍️0
XWAVXALMIMAN XWAVXALMIMAN 1 week ago
No comment on Blackrock report owning over 5% of Capricor?
30 will be here soon. Maybe a short squeeze will pop us up to 40
👍️0
Laster Laster 1 week ago
You never know but these $20 stocks tend to move to $25 or even $30.
I wouldn’t mind a nice 25% profit here.
👍️0
Volcano Volcano 2 weeks ago
The small float is getting locked up by big boys everyday
My prediction $30 by Thanksgiving and $50 by Christmas and $100 upon FDA approval in early next year
Thus became the millionaire stock indeed
👍️0
Mionaer1 Mionaer1 2 weeks ago
Piper Sandler PT $35

Piper Sandler analyst Edward Tenthoff initiates coverage on Capricor Therapeutics (NASDAQ: $CAPR) with an Overweight rating and a price target of $35.00.

The analyst comments: "Capricor is developing deramiocel (CAP-1002) to treat cardiomyopathy in Duchenne Muscular Dystrophy (DMD) boys. In the Phase II HOPE-2 trial (N=20), deramiocel slowed LVEF decline by 107% vs. placebo at 12 months. (p=0.002) At World Muscle Society, HOPE-2 OLE data showed deramiocel achieved an 8.1 point improvement in median LVEF and 11.0ml/m2 benefit in median End Systolic Volume vs. external controls at 2 years with benefit maintained out to 3 years. Capricor has begun the rolling BLA submission, and deramiocel could gain FDA approval for DMD cardiomyopathy in 2H:25. Deramiocel is partnered globally with Nippon Shinyaku with Capricor retaining 30-50% of potential blockbuster revenues, plus up to $1.5 billion in milestones. Capricor recently issued 5.1 million shares at $17 raising gross proceeds of $86 million, bringing pro forma cash to ~ $198 million excluding 3Q:24 burn."
👍️0
ed3/6me ed3/6me 2 weeks ago
time will tell
👍️0
Mionaer1 Mionaer1 2 weeks ago
$12? Never. $17 is the new floor IMO.
👍️0
ed3/6me ed3/6me 2 weeks ago
My thought is slide back to 12-15 then move to 21-25. Dip again then about 20%up. Never straight unless flooring news
👍️0
Volcano Volcano 2 weeks ago
This beast will keep moving up in the coming days
FDA approval is guaranteed and secured huge fund
I expect $50 by Christmas and $100 next year
I am a millionaire here
👍️0
GreedyAgorist GreedyAgorist 2 weeks ago
Looks like they are not even asking enough for them.

"Capricor Therapeutics (CAPR) said Thursday that it priced an underwritten offering of about 4.4 million shares at $17 per share..."

I knew the dilution was coming. I guess I was hoping that news would be later, not this week. Like the earnings report that will be a negative number (but not as negative as last quarter).

Dips are buying opportunities, but when they are based on fundamental rules of supply and demand, I wonder if there is a hurry any more. Need to know what the new plateau is. Again, I guess it was too much to ask for that to be established after this week.

: - }
👍️0
XWAVXALMIMAN XWAVXALMIMAN 2 weeks ago
It looked like we would hold at 20. Then they diluted our shares. I hate when that happens. Didn’t they have enough cash to survive until we would be profitable? Hopefully good news is coming and that extra money will be used for growth
👍️0
GreedyAgorist GreedyAgorist 2 weeks ago
Arrgghh, they could not wait to dilute, huh? I just needed a couple more days.

Feels like somebody got the info early, too. I have to wonder what price they are getting. Today's high? The after hours' low?
👍️0
ed3/6me ed3/6me 3 weeks ago
They sell today? Would be another k in your pocket
👍️0
XWAVXALMIMAN XWAVXALMIMAN 3 weeks ago
Great day today. We started out down and then reversed and had trouble getting thru 20. Since I was having eye surgery today, I put in to sell 7250 shares at 20.20. It looked good for a while when we went down to low 19’s. I tried to buy back at 18.65 but never got there. This was my 3rd time selling and buying back and selling again. I’m done. Keeping my 40.000 shares until we get to 30-40.

We ran up to 23.40 before some profit taking. Some of you are looking for a 10% correction. I use Fibonacci numbers / Elliott Wave.
We went from 4 to 22 which is 18 and then went down to around 15; a 7 point retracement. 7/18 is around 38%.

Next Wave took us from 15 to 23+. Going up 8 points means that selling should take us down 3. Expect support at 20 before the next big up move.Have a great week. Let’s Go Mets and Guardians!
👍️0
D-bol D-bol 3 weeks ago
DRUG We need a move like this one today!!
👍️0
D-bol D-bol 3 weeks ago
I’m with you
👍️0
Volcano Volcano 3 weeks ago
Yep
Still waiting for $100 Pps
👍️0
D-bol D-bol 3 weeks ago
Volcano are you still here? Haven’t heard from you in a while.
👍️0
GreedyAgorist GreedyAgorist 3 weeks ago
Just another day at the office with Capricor. Up 15%+ again. Do we get the 10% sell off before resuming the climb? That would still be a respectable gain of 7.5%. If we close above 22, that will be rarefied air for anyone in this for less than 6 years. Held the 21 handle briefly two weeks ago.

I have already played a couple of dips this week. Now waiting for a legitimate correction.
👍️0
XWAVXALMIMAN XWAVXALMIMAN 3 weeks ago
Thanks Ed. I tried to sell 7250 at 19.80 which I had bought at 18.80. Still holding my 40,000 shares.
I’m buying some XRP with my profits and averaging down on some of my other losers. taking out some cash for vacations
👍️0
TechandBio TechandBio 3 weeks ago
Next leg up will come in time patience!

$CAPR
👍️0
ed3/6me ed3/6me 3 weeks ago
agree. think retracement over till 25-30 range then probably 20% retract. but for the most part your bulk idea is solid. using 20-25% of your shares is a good way to hedge and try to get free shares. You already have profit so use it.
👍️0
XWAVXALMIMAN XWAVXALMIMAN 3 weeks ago
15.35 could be a good retracement of about 35% of the gain. We might retest that level but I wouldn’t risk it.
HC Wainwright raised their target from 40 to 70. I’m holding my core of 40,000 shares but I’m trading 7-10,000 shares for travel spending money. Planning a safari for my wife’s 70th. Sold over 20 twice and bought back at 17-18. If I can make 2-3 several times I’ll take it. If I sell and it never comes down for me to buy back, that’s fine too. I’ll still have my core. Good luck to everyone.
👍️0
GreedyAgorist GreedyAgorist 3 weeks ago
Day trading this one would have been fun. Actually, since there are only monthly options available on Capricor, I just sold a few more contracts expiring next week. I hardly ever buy options any more, although I did get into and out of a couple contracts expiring today on another ticker. Used the profit to cover the cost of a protective put here on this one. That should calm the nerves a bit next week as the expiration clock starts ticking louder. Not rooting for a down Monday, but if it comes, I will be ready.

Note to self: buy low, sell high.
👍️0
ed3/6me ed3/6me 3 weeks ago
You get in some day trade action?
👍️0
GreedyAgorist GreedyAgorist 3 weeks ago
Fun day: up 18% first thing in AM, then down 17%, only to recover 5%. If you only looked at the modest 3.8% green at the end of the day, you might have no clue as to the action. Unless, of course, you've been here for more than a few days.

; - )

Must remember to keep powder dry and trigger finger limber for another one like that.
👍️0
ed3/6me ed3/6me 3 weeks ago
Breather done. Told you16
👍️0
TechandBio TechandBio 3 weeks ago
Shorts runnning for the hills 101 LOL lets chop them up!

$CAPR
👍️0
TechandBio TechandBio 3 weeks ago
Sweet!

$40.00 Target!

$CAPR
👍️0
GreedyAgorist GreedyAgorist 3 weeks ago
Nevertheless, two days in a row of correction percentages was a bit much after almost all green for three weeks. Really three days of -10% if you start from the early morning top of Tuesday.

And as I type this, it seems to be bouncing quite strongly in the final hour or so. Will you accept 15.35 as low enough for that retracement?

: - )
👍️0
TechandBio TechandBio 3 weeks ago
Adding some vertical call debit spreads this morning for Q1 2025

$CAPR
👍️0
TechandBio TechandBio 3 weeks ago
Can't go straight up $40.00 Target in 2025 up 500%+ in 2024 was down 80% not that long big trend change.
$CAPR
👍️0
ed3/6me ed3/6me 3 weeks ago
Sounds right. You were smart if you sold out around 21. Buy back at 16
👍️0
XWAVXALMIMAN XWAVXALMIMAN 3 weeks ago
We went from 4 to 22, a gain of 18. If you follow Elliott Wave Theory and Fibonacci numbers, it would be normal to give back 38% of the gain before the next wave up. We should go down to 15.16 and then have a huge upward move up to 45.
👍️0
ed3/6me ed3/6me 3 weeks ago
people just taking profits. nothing new. as it drops it opens up new people to the company. does not hurt unless you sell in panic
👍️0
GreedyAgorist GreedyAgorist 3 weeks ago
Resistance hit yesterday; where is the support today? Is this thing looking to finish next week around 17.50? Open interest for October 18 options suggest a lot of people will be disappointed if this does not get back to 20 by then.

: - {

Right now, finishing at 15 next week is again a possibility. That, too, would be disappointing to many here.

Traders would probably file this under "buy the rumor, sell the news." Or buy before the conference; sell into the conference.
👍️0
TechandBio TechandBio 3 weeks ago
The pipeline is being overlooked Developing Transformative Cell and Exosome-based Therapeutic is going to tremendous.

$CAPR
👍️0
GreedyAgorist GreedyAgorist 4 weeks ago
I do not know; seems to be resistance once we get the 21 handle.

20% correction yesterday. Over 18% pop this morning. Lost about half that gain since then. Definitely getting bounced around.

I'm going to have to be more nimble if I want to open any more short term option contracts. (Only ten days to go.)
👍️0
TechandBio TechandBio 4 weeks ago
CAPR I'm up 480% YTD haven't sold a share. Looking for more appreciation!

$CAPR
👍️0
Mercedes99 Mercedes99 4 weeks ago
$30.00 by Nov 15th
👍️0
XWAVXALMIMAN XWAVXALMIMAN 4 weeks ago
Volcano called iron 8/21. Catching up on older posts. When do we get to 30?
👍️0
GreedyAgorist GreedyAgorist 4 weeks ago
So, it sounds like the answer is No. Neither of us has enough shares.

: - )

Well, I am definitely at least half right.

As for hitting that magical big round number target that people still dream about (even though inflation has destroyed the value, so it's just a number)... heck, I just need this quarter to be as good as last quarter, and I will be in good shape. It won't be as easy, as I don't think I have another quadruple like CAPR in my portfolio.

Looks like I just closed my October 20 call position at 2 bucks a contract. I know it is tempting to hold out for more when the thing is running, to wait and see where it ends up, but I opened that play a few days ago. My rule is: if immediately proved right, take profits; no need to wait until expiration. Besides, I also had October 15's. By cutting that position in half, I can let the rest (all house money) run. Well above the option strike price now. I will sell more cash covered puts if and when it dips.
👍️0
Volcano Volcano 4 weeks ago
Keep going up everyday
Billion dollars FDA approval guaranteed
👍️0
Volcano Volcano 4 weeks ago
I have enough shares to become millionaire
👍️0
XWAVXALMIMAN XWAVXALMIMAN 1 month ago
Congratulations to all longs who have kept the faith.
I am replying to my last post from 1/3/24. I am still holding my 50,000 shares since 2020. I sold some and bought back more. Last buy was 11/15/23 at 3.30. I have listened to every conference call. The last one was amazing. I like the way Linda is talking about other types of DMD and other kinds of cardiomyopathy. As you see with Ozempic, once a drug is approved for 1 indication, it can be used for whatever the doctor wants to prescribe it for as long as there is some research showing that it can help. I also like the way we are positioned to ramp up in Europe and Japan.

I think we are an excellent candidate to be bought out by Amgen or another big biotech or Pharma. I’m considering selling 10,000 shares and buying back 1.00 lower. If I could do that 3-4 times, I’ll be happy but I’ll be happier if I sell and never get the chance to buy back. Holding 40,000 shares until we go much higher or get bought out.

Let’s Go Mets!!
👍️0

Your Recent History

NASDAQ
CAPR
Capricor Therapeutics
NASDAQ
SAIC
Science Applications
NASDAQ
TECX
Tectonic Therapeutic
AMEX
BPW
TSX
ARIS
Aris Gold
BIT
F37431
Vontobel Financial Produ...
COIN
L3PUSD
Lepricon
BIT
P109U2
Bnp Paribas Issuance
BIT
TEF
Telefonica
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved